BafnaPharmaceuticals BAFNAPH full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Bafna Pharmaceuticals BAFNAPH WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
Daily price and charts and targets BafnaPharmaceuticals
Strong Daily Stock price targets for BafnaPharmaceuticals BAFNAPH are 102.18 and 106.17
| Daily Target 1 | 101.29 |
| Daily Target 2 | 103.07 |
| Daily Target 3 | 105.28333333333 |
| Daily Target 4 | 107.06 |
| Daily Target 5 | 109.27 |
Daily price and volume Bafna Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 01 September 2025 | 104.84 (0.94%) | 107.00 | 103.51 - 107.50 | 0.5837 times | Fri 29 August 2025 | 103.86 (4.6%) | 103.90 | 99.89 - 104.25 | 0.7489 times | Thu 28 August 2025 | 99.29 (-1.13%) | 105.44 | 98.51 - 105.44 | 1.5131 times | Tue 26 August 2025 | 100.42 (5%) | 97.00 | 96.02 - 100.42 | 0.4559 times | Mon 25 August 2025 | 95.64 (-0.13%) | 95.77 | 91.20 - 97.35 | 0.5947 times | Fri 22 August 2025 | 95.76 (-3.78%) | 101.81 | 94.54 - 104.49 | 1.4679 times | Thu 21 August 2025 | 99.52 (-4.01%) | 100.61 | 98.51 - 101.74 | 0.4476 times | Wed 20 August 2025 | 103.68 (-5%) | 108.20 | 103.68 - 110.99 | 0.5844 times | Tue 19 August 2025 | 109.14 (-5%) | 114.89 | 109.14 - 114.97 | 0.7611 times | Mon 18 August 2025 | 114.89 (5%) | 114.89 | 109.90 - 114.89 | 2.8427 times | Thu 14 August 2025 | 109.42 (9.99%) | 109.42 | 104.10 - 109.42 | 2.6176 times |
Weekly price and charts BafnaPharmaceuticals
Strong weekly Stock price targets for BafnaPharmaceuticals BAFNAPH are 102.18 and 106.17
| Weekly Target 1 | 101.29 |
| Weekly Target 2 | 103.07 |
| Weekly Target 3 | 105.28333333333 |
| Weekly Target 4 | 107.06 |
| Weekly Target 5 | 109.27 |
Weekly price and volumes for Bafna Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 01 September 2025 | 104.84 (0.94%) | 107.00 | 103.51 - 107.50 | 0.2666 times | Fri 29 August 2025 | 103.86 (8.46%) | 95.77 | 91.20 - 105.44 | 1.5131 times | Fri 22 August 2025 | 95.76 (-12.48%) | 114.89 | 94.54 - 114.97 | 2.7879 times | Thu 14 August 2025 | 109.42 (28.14%) | 87.70 | 81.03 - 109.42 | 2.3749 times | Fri 08 August 2025 | 85.39 (-0.28%) | 85.18 | 78.18 - 89.30 | 0.2787 times | Fri 01 August 2025 | 85.63 (-4.88%) | 93.60 | 84.70 - 93.60 | 0.2444 times | Fri 25 July 2025 | 90.02 (1.29%) | 88.87 | 86.77 - 91.49 | 0.2489 times | Fri 18 July 2025 | 88.87 (6.6%) | 83.00 | 81.61 - 91.95 | 0.4013 times | Fri 11 July 2025 | 83.37 (-6.55%) | 91.30 | 81.23 - 91.30 | 0.3668 times | Fri 04 July 2025 | 89.21 (-28.8%) | 87.90 | 85.06 - 94.99 | 1.5174 times | Tue 24 May 2022 | 125.30 (-0.56%) | 126.00 | 124.35 - 130.65 | 0.0233 times |
Monthly price and charts BafnaPharmaceuticals
Strong monthly Stock price targets for BafnaPharmaceuticals BAFNAPH are 102.18 and 106.17
| Monthly Target 1 | 101.29 |
| Monthly Target 2 | 103.07 |
| Monthly Target 3 | 105.28333333333 |
| Monthly Target 4 | 107.06 |
| Monthly Target 5 | 109.27 |
Monthly price and volumes Bafna Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 01 September 2025 | 104.84 (0.94%) | 107.00 | 103.51 - 107.50 | 0.0724 times | Fri 29 August 2025 | 103.86 (18.82%) | 87.70 | 78.18 - 114.97 | 1.8929 times | Thu 31 July 2025 | 87.41 (-30.24%) | 87.90 | 81.23 - 94.99 | 0.7491 times | Tue 24 May 2022 | 125.30 (-7.56%) | 139.70 | 120.70 - 139.70 | 0.1171 times | Fri 29 April 2022 | 135.55 (7.03%) | 124.65 | 124.65 - 140.00 | 0.2796 times | Thu 31 March 2022 | 126.65 (4.67%) | 119.50 | 114.50 - 145.00 | 1.3114 times | Mon 28 February 2022 | 121.00 (-13.63%) | 147.00 | 119.10 - 185.50 | 3.9482 times | Mon 31 January 2022 | 140.10 (-8.16%) | 155.60 | 130.40 - 160.15 | 0.467 times | Fri 31 December 2021 | 152.55 (30.22%) | 117.00 | 113.30 - 152.55 | 0.7037 times | Tue 30 November 2021 | 117.15 (-3.82%) | 125.70 | 116.20 - 149.15 | 0.4586 times | Fri 29 October 2021 | 121.80 (-5.18%) | 131.05 | 119.90 - 144.60 | 0.3447 times |
Indicator Analysis of BafnaPharmaceuticals
Tomorrow's movement Prediction of Bafna Pharmaceuticals BAFNAPH appears to be in uptrend. But this trend seems to be weakening.
Price is above an important level of 100.21 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Bafna Pharmaceuticals BAFNAPH made a big move recently. This generally happens when there is a positive sentiment change, or a block deal went through. There is a good chance that this trend might continue in coming days.
Munafa value: 65 as on Mon 01 September 2025
If this Munafa value is near or nearing 100, then this stock might show an upward movement. However, if this value is near or nearing 10, then this stock might very well show a downward movement.
If the Munafa value is near 50, then the stock might show a sideways movement.
SMA20 is at 97 and price is deviating by 10 points
Upper Bollinger band is at 116 and lower is at 78, while middle bands are at 87 and 106
Price is rising
Price is above 20day SMA
Price is in lower range of bands
Price action analysis of BafnaPharmaceuticals (BAFNAPH) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for BafnaPharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for BafnaPharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
BafnaPharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for BafnaPharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of BafnaPharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 104.72 and BafnaPharmaceuticals BAFNAPH stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the BafnaPharmaceuticals BAFNAPH stock. Volume based technical analysis of BafnaPharmaceuticals BAFNAPH stock is negative.
BafnaPharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Bafna Pharmaceuticals BAFNAPH
DMA (daily moving average) of Bafna Pharmaceuticals BAFNAPH
| DMA period | DMA value |
| 5 day DMA | 100.81 |
| 12 day DMA | 103 |
| 20 day DMA | 96.38 |
| 35 day DMA | 92.96 |
| 50 day DMA | 96.83 |
| 100 day DMA | 113.39 |
| 150 day DMA | 122.89 |
| 200 day DMA | 124.64 |
EMA (exponential moving average) of Bafna Pharmaceuticals BAFNAPH
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 102.21 | 100.89 | 99.4 |
| 12 day EMA | 100.21 | 99.37 | 98.55 |
| 20 day EMA | 98.63 | 97.98 | 97.36 |
| 35 day EMA | 99.32 | 98.99 | 98.7 |
| 50 day EMA | 99.79 | 99.58 | 99.41 |
SMA (simple moving average) of Bafna Pharmaceuticals BAFNAPH
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 100.81 | 98.99 | 98.13 |
| 12 day SMA | 103 | 101.8 | 100.8 |
| 20 day SMA | 96.38 | 95.5 | 94.71 |
| 35 day SMA | 92.96 | 92.39 | 91.85 |
| 50 day SMA | 96.83 | 97.25 | 97.7 |
| 100 day SMA | 113.39 | 113.58 | 113.76 |
| 150 day SMA | 122.89 | 123.06 | 123.28 |
| 200 day SMA | 124.64 | 124.75 | 124.87 |
Terms of Use Stock Market News! © munafasutra.org2025 All Rights reserved.